Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to describe the effect of TRAVATAN 0.004% Ophthalmic
Solution on aqueous humor dynamics in subjects with a clinical diagnosis of open angle
glaucoma (OAG) or ocular hypertension (OHT).